首页 | 本学科首页   官方微博 | 高级检索  
     


Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal Cancer
Affiliation:1. Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, University Heidelberg, Im Neuenheimer Feld 110, 69120 Heidelberg, Germany;2. Cell Biology and Biophysics Unit, European Molecular Biology Laboratory, Meyerhofstrasse 1, 69117 Heidelberg, Germany;3. Biochemistry Center, University of Heidelberg, 69120 Heidelberg, Germany;4. Department of Pharmacology and Tianjin Key Laboratory of Inflammation Biology, School of Basic Medical Sciences, Tianjin Medical University, 300070, Tianjin, China;5. Genome Biology Unit, European Molecular Biology Laboratory, 69117 Heidelberg, Germany;6. European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany;7. Section of Molecular Immunology, Institute of Immunology, University Hospital Heidelberg, 69120 Heidelberg, Germany;8. Thoracic Hospital, University Hospital Heidelberg, University Heidelberg, 69126 Heidelberg, Germany;9. Translational Lung Research Centre (TLRC) Heidelberg, Member of the German Centre for Lung Research (DZL), 69120 Heidelberg, Germany
Abstract:
><ol class=
  • Download : Download high-res image (242KB)
  • Download : Download full-size image
  • Keywords:tissue stiffness  atomic force microscopy  anti-angiogenic therapy  bevacizumab  RAS signaling  metastatic colorectal cancer  fibroblasts  CAFs  MAFs
    本文献已被 ScienceDirect 等数据库收录!
    设为首页 | 免责声明 | 关于勤云 | 加入收藏

    Copyright©北京勤云科技发展有限公司  京ICP备09084417号